133 related articles for article (PubMed ID: 25386842)
1. New insights into ADAMs regulation of the GRO-α/CXCR2 system: focus on Sjögren's syndrome.
Sisto M; Lisi S
Int Rev Immunol; 2015; 34(6):486-99. PubMed ID: 25386842
[TBL] [Abstract][Full Text] [Related]
2. GRO-α/CXCR2 system and ADAM17 correlated expression in Sjögren's syndrome.
Lisi S; Sisto M; Lofrumento DD; D'Amore M; De Lucro R; Ribatti D
Inflammation; 2013 Jun; 36(3):759-66. PubMed ID: 23389772
[TBL] [Abstract][Full Text] [Related]
3. A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: regulatory effects of pro-inflammatory cytokines.
Lisi S; Sisto M; Lofrumento DD; D'Amore M; De Lucro R; Ribatti D
Histochem Cell Biol; 2013 Feb; 139(2):371-9. PubMed ID: 23052840
[TBL] [Abstract][Full Text] [Related]
4. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.
Kershaw MH; Wang G; Westwood JA; Pachynski RK; Tiffany HL; Marincola FM; Wang E; Young HA; Murphy PM; Hwu P
Hum Gene Ther; 2002 Nov; 13(16):1971-80. PubMed ID: 12427307
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis.
Lisi S; Sisto M; Lofrumento DD; Cucci L; Frassanito MA; Mitolo V; D'Amore M
J Autoimmun; 2010 Sep; 35(2):160-70. PubMed ID: 20673622
[TBL] [Abstract][Full Text] [Related]
6. ADAM17 at the interface between inflammation and autoimmunity.
Lisi S; D'Amore M; Sisto M
Immunol Lett; 2014 Nov; 162(1 Pt A):159-69. PubMed ID: 25171914
[TBL] [Abstract][Full Text] [Related]
7. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
8. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
[TBL] [Abstract][Full Text] [Related]
9. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
Sisto M; Lisi S; Lofrumento DD; D'Amore M; Frassanito MA; Ribatti D
Genes Immun; 2012 Jul; 13(5):411-20. PubMed ID: 22513453
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression.
Boisvert WA; Rose DM; Johnson KA; Fuentes ME; Lira SA; Curtiss LK; Terkeltaub RA
Am J Pathol; 2006 Apr; 168(4):1385-95. PubMed ID: 16565511
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus diminishes the expression of GRO-α (CXCL-1) /CXCR2 axis in human keratinocytes and cutaneous squamous cell carcinoma cells.
Schaper-Gerhardt K; Hansel A; Walter A; Grimmelmann I; Gutzmer R
J Dermatol Sci; 2021 Oct; 104(1):30-38. PubMed ID: 34479772
[TBL] [Abstract][Full Text] [Related]
12. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions.
Filipovic R; Jakovcevski I; Zecevic N
Dev Neurosci; 2003; 25(2-4):279-90. PubMed ID: 12966224
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms.
Kyriakidis NC; Kapsogeorgou EK; Tzioufas AG
J Autoimmun; 2014 Jun; 51():67-74. PubMed ID: 24333103
[TBL] [Abstract][Full Text] [Related]
14. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer.
Korbecki J; Kupnicka P; Chlubek M; Gorący J; Gutowska I; Baranowska-Bosiacka I
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216283
[TBL] [Abstract][Full Text] [Related]
15. Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17).
Mishra HK; Long C; Bahaie NS; Walcheck B
J Leukoc Biol; 2015 Mar; 97(3):447-54. PubMed ID: 25412626
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
Fox PC
Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
[TBL] [Abstract][Full Text] [Related]
17. The chemokine CXCL1/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons.
Wang JG; Strong JA; Xie W; Yang RH; Coyle DE; Wick DM; Dorsey ED; Zhang JM
Mol Pain; 2008 Sep; 4():38. PubMed ID: 18816377
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils regulate their own apoptosis via preservation of CXC receptors.
Dunican A; Grutkoski P; Leuenroth S; Ayala A; Simms HH
J Surg Res; 2000 May; 90(1):32-8. PubMed ID: 10781372
[TBL] [Abstract][Full Text] [Related]
20. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
